Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LysaKare serum potassium safety study in GEP-NET patients eligible for Lutathera
2019-004073-76Phase 4Completed
- Sponsor
- Advanced Accelerator Applications
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lysine + arginine in Gastroenteropancreatic Carcinoid Tumor, sponsored by Advanced Accelerator Applications. Primary endpoint: Change in serum potassium levels. Started Jun 2020; status: completed.
02
Drugs
lysine + arginine
03
Conditions
Gastroenteropancreatic Carcinoid Tumor
Beyond the preview
Go deeper on 2019-004073-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004073-76.